CN113481294B - 核酸样品的制备方法 - Google Patents

核酸样品的制备方法 Download PDF

Info

Publication number
CN113481294B
CN113481294B CN202110830137.XA CN202110830137A CN113481294B CN 113481294 B CN113481294 B CN 113481294B CN 202110830137 A CN202110830137 A CN 202110830137A CN 113481294 B CN113481294 B CN 113481294B
Authority
CN
China
Prior art keywords
skin
nucleic acid
subject
skin surface
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110830137.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN113481294A (zh
Inventor
井上高良
八谷辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to CN202110830137.XA priority Critical patent/CN113481294B/zh
Publication of CN113481294A publication Critical patent/CN113481294A/zh
Application granted granted Critical
Publication of CN113481294B publication Critical patent/CN113481294B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
    • B32B5/18—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by features of a layer of foamed material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CN202110830137.XA 2016-07-08 2017-06-07 核酸样品的制备方法 Active CN113481294B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110830137.XA CN113481294B (zh) 2016-07-08 2017-06-07 核酸样品的制备方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JPPCT/JP2016/070343 2016-07-08
JP2016070343 2016-07-08
CN202110830137.XA CN113481294B (zh) 2016-07-08 2017-06-07 核酸样品的制备方法
PCT/JP2017/021040 WO2018008319A1 (ja) 2016-07-08 2017-06-07 核酸試料の調製方法
CN201780012761.0A CN108699589B (zh) 2016-07-08 2017-06-07 核酸样品的制备方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201780012761.0A Division CN108699589B (zh) 2016-07-08 2017-06-07 核酸样品的制备方法

Publications (2)

Publication Number Publication Date
CN113481294A CN113481294A (zh) 2021-10-08
CN113481294B true CN113481294B (zh) 2024-03-12

Family

ID=60912100

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202110830137.XA Active CN113481294B (zh) 2016-07-08 2017-06-07 核酸样品的制备方法
CN201780012761.0A Active CN108699589B (zh) 2016-07-08 2017-06-07 核酸样品的制备方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201780012761.0A Active CN108699589B (zh) 2016-07-08 2017-06-07 核酸样品的制备方法

Country Status (6)

Country Link
US (2) US11913061B2 (enExample)
EP (2) EP3719138B1 (enExample)
JP (3) JP6231252B1 (enExample)
KR (1) KR101961076B1 (enExample)
CN (2) CN113481294B (enExample)
WO (1) WO2018008319A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3875585A4 (en) * 2018-11-01 2022-11-16 Kao Corporation Method for preparing nucleic acid derived from skin cell of subject
CN114945683A (zh) * 2020-01-10 2022-08-26 花王株式会社 核酸扩增方法
CN115279901A (zh) * 2020-03-11 2022-11-01 花王株式会社 来自皮肤表面脂质的rna的制备方法
WO2021215532A1 (ja) 2020-04-24 2021-10-28 花王株式会社 月経前症候群の重症度検出方法
JP2021175381A (ja) * 2020-05-01 2021-11-04 花王株式会社 アトピー性皮膚炎の検出方法
WO2021221138A1 (ja) 2020-05-01 2021-11-04 花王株式会社 アトピー性皮膚炎の検出方法
JP2021175958A (ja) * 2020-05-01 2021-11-04 花王株式会社 アトピー性皮膚炎検出用タンパク質マーカーの調製方法
JP2021175382A (ja) * 2020-05-01 2021-11-04 花王株式会社 乳幼児アトピー性皮膚炎の検出方法
CN115605613A (zh) 2020-05-14 2023-01-13 花王株式会社（Jp） Rna信息的数据处理方法
CN115605608A (zh) 2020-05-14 2023-01-13 花王株式会社（Jp） 帕金森氏病的检测方法
EP4180536A4 (en) 2020-07-10 2024-08-07 Kao Corporation Method for detecting severity of atopic dermatitis
JP7603552B2 (ja) 2020-08-28 2024-12-20 花王株式会社 Ｒｎａの保存方法
JP7840855B2 (ja) 2020-08-28 2026-04-06 花王株式会社 検体保存具
EP4215622A4 (en) 2020-09-16 2024-11-20 Kao Corporation METHOD FOR DETECTING CHILDHOOD ATOPIC DERMATITIS
WO2022114200A1 (ja) 2020-11-30 2022-06-02 花王株式会社 アトピー性皮膚炎の症度の検出方法
JP7655721B2 (ja) * 2020-12-18 2025-04-02 花王株式会社 疲労マーカー及びそれを用いた疲労の検出方法
JP7655720B2 (ja) * 2020-12-18 2025-04-02 花王株式会社 ストレスマーカー及びそれを用いた慢性ストレスレベルの検出方法
JP7623827B2 (ja) * 2020-12-18 2025-01-29 花王株式会社 睡眠状態マーカー及びそれを用いた睡眠状態の検出方法
JP2022123874A (ja) * 2021-02-12 2022-08-24 花王株式会社 皮膚角層由来の核酸試料の調製方法
JP2022164646A (ja) * 2021-04-15 2022-10-27 花王株式会社 乳幼児おむつ皮膚炎の症度の検出方法
CN117413069A (zh) 2021-05-31 2024-01-16 花王株式会社 皮肤表面脂质检体内部标准基因
JP7750481B2 (ja) * 2021-06-22 2025-10-07 花王株式会社 内臓脂肪面積の検出方法
JP2023002298A (ja) * 2021-06-22 2023-01-10 花王株式会社 糖尿病指標値の検出方法
JP2023038883A (ja) * 2021-09-07 2023-03-17 花王株式会社 ＳＡＲＳ－ＣｏＶ－２の検出方法
JP7851106B2 (ja) * 2021-11-19 2026-04-24 花王株式会社 炭酸ガス製剤の有効性を検出する方法
NL2030378B1 (en) 2021-12-31 2023-07-05 Lumicks Ca Holding B V Selecting forces for means and methods involving cellular avidity
WO2024111617A1 (ja) 2022-11-24 2024-05-30 花王株式会社 皮膚表上脂質検体内部標準遺伝子
WO2025084419A1 (ja) * 2023-10-20 2025-04-24 花王株式会社 肌タイプの分類方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103782174A (zh) * 2011-06-07 2014-05-07 卡里斯生命科学卢森堡控股有限责任公司 用于癌症的循环生物标志物

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003533965A (ja) * 1998-08-14 2003-11-18 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド 皮膚の異常症状を治療するためのヒト・ステアロイル−ＣｏＡデサチュラーゼ−関連組成物および方法
AU5774699A (en) * 1998-08-14 2000-03-06 Johnson & Johnson Consumer Companies, Inc. Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders
US6638611B2 (en) * 2001-02-09 2003-10-28 3M Innovative Properties Company Multipurpose cosmetic wipes
US6645611B2 (en) * 2001-02-09 2003-11-11 3M Innovative Properties Company Dispensable oil absorbing skin wipes
US6649181B1 (en) * 2002-05-29 2003-11-18 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Cosmetic adhesive strip
JP2005192409A (ja) 2003-12-26 2005-07-21 Shiseido Co Ltd 体毛からｒｎａを抽出するための方法
DK1734814T3 (en) 2004-03-17 2015-04-07 Revivicor Inc Tissue DERIVED FROM ANIMALS IS MISSING ANY EXPRESSION OF FUNCTIONAL ALPHA-1,3 galactosyltransferase
US7183057B2 (en) 2004-03-31 2007-02-27 Dermtech International Tape stripping methods for analysis of skin disease and pathological skin state
KR101267430B1 (ko) * 2006-10-04 2013-05-30 문우철 핵산을 안정적으로 보관하는 새로운 피부 유전자 카드와이를 이용한 유전자 분석방법, 그리고 이의 응용 방법
JP2008222876A (ja) * 2007-03-13 2008-09-25 Institute Of Physical & Chemical Research 生分解性吸油用フィルム
WO2009003654A2 (en) * 2007-06-29 2009-01-08 Medizinische Universität Innsbruck Selecting nucleic acid samples suitable for genotyping
BRPI0913578A2 (pt) 2008-05-14 2017-06-06 Dermtech Int diagnose de melanoma e lentigo solar por análise de ácido nucléico
JP2010115178A (ja) * 2008-11-14 2010-05-27 Nippon Menaade Keshohin Kk 皮膚の炎症の予測方法及びその用途
JP2011019505A (ja) 2009-01-29 2011-02-03 Mukogawa Gakuin 特定遺伝子を検出する方法
EP3369828B1 (en) * 2011-02-07 2020-07-15 The Governing Council Of The University Of Toronto Bioprobes and methods of use thereof
EP2742148B1 (en) * 2011-08-11 2017-06-28 Hummingbird Diagnostics GmbH Complex sets of mirnas as non-invasive biomarkers for psoriasis
US20150086581A1 (en) * 2012-03-17 2015-03-26 The Regents Of The University Of California Fast Diagnosis and Personalized Treatment for Acne
CN108949772A (zh) * 2012-04-02 2018-12-07 现代泰克斯公司 用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸
WO2013151663A1 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of membrane proteins
EP2857521A4 (en) 2012-05-31 2015-12-30 Takeda Pharmaceutical METHOD FOR ASSESSING ENDOMETRIOSIS
FR2993282B1 (fr) 2012-07-13 2017-11-10 Expanscience Lab Procede d'identification de marqueurs moleculaires de la peau d'enfant
US20150301058A1 (en) 2012-11-26 2015-10-22 Caris Science, Inc. Biomarker compositions and methods
CN119655753A (zh) 2012-12-14 2025-03-21 明德拉公司 用于检测和获取生物标志物的方法和装置
JP5895244B2 (ja) 2014-06-27 2016-03-30 株式会社ライラック研究所 機能性化粧水
JP6650240B2 (ja) 2014-11-25 2020-02-19 花王株式会社 メラニン制御剤の探索方法
WO2016172598A1 (en) * 2015-04-22 2016-10-27 The Broad Institute Inc. Exosomes and uses thereof
WO2016191644A1 (en) * 2015-05-28 2016-12-01 Lucigen Corporation Molecular detection of rna

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103782174A (zh) * 2011-06-07 2014-05-07 卡里斯生命科学卢森堡控股有限责任公司 用于癌症的循环生物标志物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DNA fingerprinting secondary transfer from different skin areas：Morphological and genetic studies;Silvia Zoppis等;Forensic Science International;第11卷;摘要、第138页、140页、图3、第142页右栏和第143页左栏 *
Molecular approaches for forensic cell type identification：on mRNA，miRNA，DNAmethylation and microbial markers;Titia Sijen等;Forensic Science Internaional;第18卷;第21-32页 *
RNA/DNA co-analysis from human skin and contact traces-results of a sixth collaborative EDNAP exercise;C.Haas等;Forensic Science Internaional;第16卷;表2 *

Also Published As

Publication number Publication date
KR101961076B1 (ko) 2019-03-21
US11913061B2 (en) 2024-02-27
JP7323671B2 (ja) 2023-08-08
JPWO2018008319A1 (ja) 2018-07-05
EP3719138B1 (en) 2022-09-21
EP3372693A4 (en) 2018-10-10
EP3372693B1 (en) 2020-02-12
JP6231252B1 (ja) 2017-11-15
WO2018008319A1 (ja) 2018-01-11
KR20180081624A (ko) 2018-07-16
EP3719138A1 (en) 2020-10-07
US20240294966A1 (en) 2024-09-05
JP2018000206A (ja) 2018-01-11
US20180371524A1 (en) 2018-12-27
CN108699589B (zh) 2021-08-13
JP2022097507A (ja) 2022-06-30
EP3372693A1 (en) 2018-09-12
CN113481294A (zh) 2021-10-08
CN108699589A (zh) 2018-10-23

Similar Documents

Publication Publication Date Title
US20240294966A1 (en) Method for preparing nucleic acid sample
JP7626515B2 (ja) 被験体の皮膚細胞に由来する核酸の調製方法
JP5311439B2 (ja) 皮膚の状態を評価する方法及びその用途
JP2020501567A (ja) 乾燥の徴候を呈している皮膚を診断するための方法
JP5653783B2 (ja) 皮膚表皮内水分保持能評価法
JP7655720B2 (ja) ストレスマーカー及びそれを用いた慢性ストレスレベルの検出方法
JP5535571B2 (ja) 表皮ターンオーバーの評価方法及びその用途
CN116635526A (zh) 特应性皮炎的重症度的检测方法
JP7860712B2 (ja) 乾燥による皮膚表面形状悪化の検出方法
JP7860715B2 (ja) 皮膚外用製剤の有効性の評価方法
JP7623827B2 (ja) 睡眠状態マーカー及びそれを用いた睡眠状態の検出方法
JP7655721B2 (ja) 疲労マーカー及びそれを用いた疲労の検出方法
JP2023069413A (ja) 被膜の皮膚保湿効果の評価方法
JP5653673B2 (ja) 皮膚血管機能評価法
JP7712792B2 (ja) Ｒｎａ情報のデータ処理方法
JP2023069499A (ja) 乾燥による皮膚表面形状悪化の検出方法
JP2021175394A (ja) 月経周期マーカー
JP2023075830A (ja) 皮膚外用製剤の有効性の評価方法
JP2010115178A (ja) 皮膚の炎症の予測方法及びその用途

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant